2008
DOI: 10.1007/s12308-008-0012-x
|View full text |Cite
|
Sign up to set email alerts
|

New developments in the pathology of malignant lymphoma: a review of the literature published from May to July 2008

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
2
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 78 publications
(60 reference statements)
2
2
0
Order By: Relevance
“…CD69 expression on tumor cells was a poor prognostic sign, and an interfollicular infiltrate of FoxP3-positive T cells was a good prognostic sign irrespective of the treatment arm, and the authors suggest that a dense infiltrate of FoxP3-positive T cells, dense and interfollicular infiltrate of CD68-positive macrophages, and complete follicular dendritic meshworks were associated with a favorable time to progression in CVP-treated patients, while being a poor prognostic sign in fludarabine-treated patients. This finding confirms the importance of moving away from prognostic marker studies and go to predictive markers (van Krieken [ 4 ]). Ai et al [ 5 ] did in vivo experiments that partially explain the findings of de Jong et al: follicular lymphoma B cells in contrast to normal B cells could induce conventional T cells to express FoxP3 and to acquire regulatory function.…”
Section: Biology Of Lymphomasupporting
confidence: 78%
“…CD69 expression on tumor cells was a poor prognostic sign, and an interfollicular infiltrate of FoxP3-positive T cells was a good prognostic sign irrespective of the treatment arm, and the authors suggest that a dense infiltrate of FoxP3-positive T cells, dense and interfollicular infiltrate of CD68-positive macrophages, and complete follicular dendritic meshworks were associated with a favorable time to progression in CVP-treated patients, while being a poor prognostic sign in fludarabine-treated patients. This finding confirms the importance of moving away from prognostic marker studies and go to predictive markers (van Krieken [ 4 ]). Ai et al [ 5 ] did in vivo experiments that partially explain the findings of de Jong et al: follicular lymphoma B cells in contrast to normal B cells could induce conventional T cells to express FoxP3 and to acquire regulatory function.…”
Section: Biology Of Lymphomasupporting
confidence: 78%
“…CD69 expression on tumor cells was a poor prognostic sign, and an interfollicmacrophages, and complete follicular dendritic meshworks were associated with a favorable time to progression in CVP-treated patients, while being a poor prognostic sign in fludarabine-treated patients. This finding confirms the importance of moving away from prognostic marker studies and go to predictive markers (van Krieken [4]). Ai et al [5] did in vivo experiments that partially explain the findings of de Jong et al: follicular lymphoma B cells in contrast to normal B cells could induce conventional T cells to express FoxP3 and to acquire regulatory function.…”
Section: B-cell Lymphomassupporting
confidence: 75%
“…In China, thyroid lymphomas were also studied, like in other countries (see previous review, van Krieken [25]). Sun et al [26] studied 40 cases and show that combined chemotherapy and radiotherapy may offer better outcome without the need for extensive resection, and surgery should be reserved to providing tissue for diagnosis.…”
Section: Epidemiology Of Lymphomamentioning
confidence: 99%